This website is intended for healthcare professionals

Clinical

A general overview of Prader-Willi syndrome

Delia Pogson outlines the pathogenesis of this rare disorder and discusses the multidisciplinary approach required to manage and treat this genetic condition

Prader-Willi syndrome (PWS) is a complex neurodevelopmental genetic condition that was first described in 1956 by Prader and colleagues. The condition is characterised by a recognisable pattern of dysmorphic features as well as major neurological, developmental, behavioural and psychiatric differences.1-5

It has been highlighted that PWS should be referred to as a genomic condition rather than a genetic condition because of its genomic imprinting feature.1,4

The genotype of PWS

Each cell in the human body contains genetic material inside its nucleus in the form of chromosomes (the genotype); 23 pairs of chromosomes composed of two strands of DNA are linked together to form a double helix, with one chromosome from each pair being inherited from each parent.

Register now for access

Thank you for visiting Independent Nurse and reading some of our premium content. To read more, please register today. 

Register

Already have an account? Sign in here